Rosen Law Firm Announces an Investigation of Securities Claims Against Homology Medicines, Inc. – FIXX

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: FIXX) resulting from allegations that Homology may have issued materially misleading business information to the investing public. On July 21, 2020, Mariner Research (“Mariner”) published a report questioning statements by Homology and its officers about the efficacy of HMI-102, the Company’s lead p